NIH Study Uncovers Details of Early Stages in Muscle Formation and Regeneration
News Apr 23, 2013
Researchers at the National Institutes of Health have identified proteins that allow muscle cells in mice to form from the fusion of the early stage cells that give rise to the muscle cells.
The findings have implications for understanding how to repair and rehabilitate muscle tissue and to understanding other processes involving cell fusion, such as when a sperm fertilizes an egg, when viruses infect cells, or when specialized cells called osteoclasts dissolve and assimilate bone tissue in order to repair and maintain bones.
Their findings were published online in the Journal of Cell Biology.
"Through a process that starts with these progenitor cells, the body forms tissue that accounts for about one-third of its total weight," said the study's senior author, Leonid V. Chernomordik, Ph.D., of the Section on Membrane Biology at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the NIH institute where the research was conducted. "Our study provides the first look at the very early stages of this fusion process."
Dr. Chernomordik conducted the study along with researchers at NICHD (Evgenia. Leikina, D.V.M.,; Kamram. Melikov, Ph.D.; Samristha Sanyal, Ph.D.; Santosh Verma, Bokke Eun, Ph.D.; Claudia Gebert, D.V.M., Ph.D.; Karl Pfeifer, Ph.D., and Vladimir.A. Lizunov, Ph.D.) and at Tel Aviv University, in Israel (Michael M. Kozlov, Ph.D.).
Muscle cells originate from precursor cells known as myoblasts. Myoblasts fuse to form a single long tubular cell called a myocyte (a muscle fiber). Muscle tissue is composed of large collections of these fibers.
The fusion of myoblasts into muscle fibers takes place early in fetal development. With exercise and throughout a person's life, the process is repeated to form new muscle mass and repair old or damaged muscle.
It takes many hours for cells to prepare for fusion, but the fusion process itself is very rapid. To study myoblast fusion, the researchers first blocked the start of the fusion process with a chemical.
Ordinarily, the mouse myoblasts the researchers worked with fuse at varied intervals. By blocking fusion, and then lifting the block, the researchers were able to synchronize fusion in a large number of cells, making the process easier to study.
The researchers identified the two distinct stages of cell fusion and the essential proteins that facilitate these stages.
In the first stage, two myoblasts meet, and proteins on cell surface membranes cause the membranes to meld.
In the second stage, a pore opens between the cells and their contents merge. This second step is guided by proteins inside the cells.
The work identifies two cell surface proteins that act at the start of myoblast fusion. These proteins belong to a large family of proteins called annexins. Annexins are also known to play a role in membrane repair and in inflammation.
The researchers identified the protein dynamin, found inside the cell, as essential to the second stage of the cell fusion process.
"Dynamin also has an unexplained link to certain rare and poorly understood myopathies - disorders characterized by underdeveloped muscles," said Dr. Chernomordik.
Dr. Chernomordik continued, "We hope that further examination of the role of dynamin in cell fusion will lead to a greater understanding of these conditions."
Bacterial Control Mechanism for Adjusting to Changing ConditionsNews
A fundamental prerequisite for life on earth is the ability of living organisms to adapt to changing environmental conditions. Physicists have now determined that the regulation mechanisms used by bacteria to adapt to different environments are based on a global control process that can be described in a single equation.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon TherapeuticsNews
Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.READ MORE